Select for export Psilocybin therapy: A novel approach to treating depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/gh9.0000000000000175 Copy citation Copy BibTeX International Journal of Surgery Global Health 2023-06-01 Tooba Noor, Areej Shakil, Aimen Waqar Khan, Syeda Mahrukh Fatima Zaidi, Hussain Sohail Rangwala, Burhanuddin Sohail Rangwala OpenAlex Published psilocybinpsilocin DepressionAnxietyAddiction Clinical Trial More
Select for export Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/s0033291723001411 PubMed 37264950 Copy citation Copy BibTeX Psychological Medicine 2023-06-01 Paul McCrone, Henry Fisher, Clare Knight, Rebecca Harding, Anne Katrin Schlag, David Nutt OpenAlex Published psilocybin DepressionChronic PainToxicity Other More
Select for export New Pharmacologic Approaches to the Treatment of Bipolar Depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s40265-023-01872-x PubMed 37227597 Copy citation Copy BibTeX Unknown journal 2023-05-24 Keramatian K, Chakrabarty T, DuBow A, Saraf G, Yatham LN. Europe PMC Published psilocybin DepressionMechanism of ActionMitochondrial Function Randomized Controlled Trial More
Select for export Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41386-023-01607-2 PubMed 37231080 Copy citation Copy BibTeX Neuropsychopharmacology 2023-05-24 Laura Ley, Friederike Holze, Denis Arikci, A. Becker, Isabelle Straumann, Aaron Klaiber OpenAlex Published psilocybin PharmacologyReceptor PharmacologyConsciousness Clinical Trial More
Select for export Time-resolved network control analysis links reduced control energy under DMT with the serotonin 2a receptor, signal diversity, and subjective experience Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2023.05.11.540409 Copy citation Copy BibTeX bioRxiv 2023-05-11 Singleton SP, Timmermann C, Luppi AI, Eckernäs E, Roseman L, Carhart-Harris RL bioRxiv PREPRINT (not peer reviewed) psilocybin Brain ImagingPharmacologyReceptor Pharmacology Other More
Select for export How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change No abstract availability was recorded for this entry. Details DOI 10.1016/j.jad.2023.04.105 PubMed 37146908 Copy citation Copy BibTeX Journal of Affective Disorders 2023-05-02 Richard J. Zeifman, Anne Catherine Wagner, Candice M. Monson, Robin Carhart-Harris OpenAlex Published psilocybin AnxietyChronic Pain Other More
Select for export Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1136/bmjopen-2022-068884 PubMed 37142308 Copy citation Copy BibTeX BMJ Open 2023-04-30 Alan K. Davis, Adam W. Levin, Paul Nagib, Stacey B. Armstrong, Rafael Lancelotta OpenAlex Published psilocybin AnxietyPTSDChronic Pain Clinical Trial More
Select for export Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1178529 PubMed 37181888 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-04-24 Terence H. W. Ching, Rachael Grazioplene, Calvin Bohner, Stephen A. Kichuk, Giuliana DePalmer, Elizabeth J. D’Amico OpenAlex Published psilocybin OCDChronic PainBrain Imaging Randomized Controlled Trial More
Select for export A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811231167848 PubMed 37122239 Copy citation Copy BibTeX Journal of Psychopharmacology 2023-04-24 Brandon Weiss, David Erritzøe, Bruna Giribaldi, David Nutt, Robin Carhart-Harris OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of Consciousness Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2023-03-28 University Hospital, Basel, Switzerland ClinicalTrials.gov CLINICAL TRIAL psilocybin Receptor PharmacologyConsciousnessSpirituality Other More
Select for export The Unique Neural Signature of Your Trip: Functional Connectome Fingerprints of Subjective Psilocybin Experience Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2023.03.20.532894 Copy citation Copy BibTeX bioRxiv 2023-03-20 Tolle HM, Farah JC, Mallaroni P, Mason NL, Ramaekers JG, Amico E. bioRxiv PREPRINT (not peer reviewed) psilocybin Brain ImagingDefault Mode NetworkAging Other More
Select for export Mood and Cognitive Effects of Low Doses of Psilocybin Observed in Healthy Subjects ("MELO"): A Blinded, Placebo-Controlled, Dose-Finding Study Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2023-03-19 Optimi Health Corporation ClinicalTrials.gov CLINICAL TRIAL psilocybinpsilocin DepressionAnxietyMicrodosing Clinical Trial More
Select for export Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811231154852 PubMed 36938991 Copy citation Copy BibTeX Journal of Psychopharmacology 2023-03-19 Jordan Sloshower, Patrick D. Skosnik, Hamideh Safi-Aghdam, Surbhi Pathania, Shariful A. Syed, Brian Pittman OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020 Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811231158245 PubMed 36876583 Copy citation Copy BibTeX Journal of Psychopharmacology 2023-03-05 Emma I Kopra, Jason Ferris, Adam Winstock, Kim P. C. Kuypers, Allan H. Young, James Rucker OpenAlex Published psilocybin PTSDChronic PainReceptor Pharmacology Observational Study More
Select for export Assessment of the acute effects of 2C-B vs psilocybin on subjective experience, mood and cognition Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2023.02.16.528808 Copy citation Copy BibTeX bioRxiv 2023-02-15 Mallaroni P, Mason NL, Reckweg JT, Paci R, Ritscher S, Toennes SW bioRxiv PREPRINT (not peer reviewed) psilocybin PharmacologyConsciousnessEmotional Processing Observational Study More
Select for export Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/psymed.2022.0004 PubMed 40047007 Copy citation Copy BibTeX Psychedelic Medicine 2023-02-15 Jacob S. Aday, Zachary Skiles, Noa Eaton, Lisa Fredenburg, Mollie Pleet, Jessica Mantia OpenAlex Published psilocybin DepressionChronic PainSpirituality Clinical Trial More
Select for export Therapeutic effect of psilocybin in addiction: A systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1134454 PubMed 36846225 Copy citation Copy BibTeX Unknown journal 2023-02-08 van der Meer PB, Fuentes JJ, Kaptein AA, Schoones JW, de Waal MM, Goudriaan AE Europe PMC Published psilocybin AddictionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jad.2023.01.108 PubMed 36740140 Copy citation Copy BibTeX Journal of Affective Disorders 2023-02-02 Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, Merve Atli, James Bennett, Megan Croal OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Randomized Controlled Trial More
Select for export Corrigendum to 'Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial'. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.eclinm.2023.101841 PubMed 36747965 Copy citation Copy BibTeX Unknown journal 2023-01-29 von Rotz R, Schindowski EM, Jungwirth J, Schuldt A, Rieser NM, Zahoranszky K Europe PMC Published psilocybin DepressionClinical Trial Clinical Trial More
Select for export Psychedelics for Patients With Cancer: A Comprehensive Literature Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/10600280221144055 PubMed 36635883 Copy citation Copy BibTeX Unknown journal 2023-01-11 White CM, Weisman N, Dalo J. Europe PMC Published psilocybin DepressionAnxietyMechanism of Action Randomized Controlled Trial More